Literature DB >> 30254390

Evaluation of anti-inflammatory effects of systemically administered curcumin, lycopene and piperine as an adjunct to scaling and root planing: A clinical study.

Supreet Kaur1, Richa Sharma1, Vandana Sarangal1, Navkiran Kaur1, Pallavi Prashar1.   

Abstract

BACKGROUND: The natural herbal extracts curcumin (Curcuma longa), lycopene and piperine demonstrated a very potent anti-inflammatory action and can be used as an antioxidant therapy in the management of inflammatory processes such as gingivitis and periodontitis. AIM AND
OBJECTIVE: The aim of the present study is to evaluate the effects of systemically administered extracts curcumin, lycopene and piperine as an adjunct to scaling and root planing (SRP) in patients with moderate gingivitis.
MATERIALS AND METHODS: Sixty systemically healthy participants with moderate gingivitis were enrolled in a randomized clinical study. Participants were randomly distributed into two treatment groups: Group I (test group) (350 mg/day antioxidant therapy) along with SRP for 3 weeks and Group II (control group) SRP alone. Clinical parameters such as plaque index, gingival index and probing pocket depth were evaluated at baseline and after 21 days using paired t-test.
RESULTS: Both the treatment groups showed statistically significant reduction in clinical parameters, but the test group showed greater reduction as compared to control group (P < 0.05).
CONCLUSION: The results concluded that systemically administered antioxidants could cause better resolution of inflammation when used as an adjunct to SRP.

Entities:  

Keywords:  Antioxidant therapy; curcumin; gingivitis; inflammation; lycopene; piperine

Year:  2017        PMID: 30254390      PMCID: PMC6153907          DOI: 10.4103/ayu.AYU_63_17

Source DB:  PubMed          Journal:  Ayu        ISSN: 0974-8520


Introduction

Periodontitis is an inflammatory process leading to periodontal attachment and bone loss initiated by plaque biofilm and products leading to tooth loss. Majority of the periodontal treatment modalities try to halt the advancement of periodontal destruction.[1] But even with application of appropriate periodontal modalities, there are some conditions or situations which remain unaffected. Although balanced nutrition and supplementation have emerged to be an important part of periodontal research, their role has not been thoroughly evaluated.[2] Hence, the factors which respond to the periodontal treatment therapy need to be recognized. Various pro-inflammatory mediators such as interleukin-1 (IL-1), IL-6, PGE2 and tumor necrosis factor alpha, ions and reactive oxygen species (ROS) are produced from the inflamed periodontal tissues. The free radicals which have a very important role in diabetes, aging have led to a medical upheaval which includes antioxidants, that is, a rising new standard of oral health care. These antioxidants scavenge the free radicals and prevent the damage caused by them hence acting as a remedial and prophylactic agents.[3] Periodontal pathogens, despite having an important role in destroying periodontal tissue, also act as a risk factor for heart diseases, lung diseases and diabetes etc. Therefore, the antioxidant status should be evaluated to address the host resistance as these influences the extent of gingival and periodontal destruction. The nutritional counseling and supplementation should be an important part of periodontal protocol to enhance the outcome of conventional periodontal therapy.[2] Lycopene is one of the most effective antioxidants found in tomatoes and has a singlet oxygen quenching ability which provides prevention against various chronic disorders.[3] Rhizomes of the plant Curcuma longa Linn. contain curcumin which is a yellow colored phenolic pigment and has a very potent anti-inflammatory action due to oxygen radical scavenging activity and uncoupling of oxidative phosphorylation. Wide-ranging scientific research has confirmed a wide gamut of therapeutic effects such as anti-inflammatory, antifungal, antibacterial and antitumor in the dose range of 200 mg/kg body weight with negligible effects on human systems.[4] Similarly, Piper nigrum (black pepper) contains an alkaloid piperine which has a very high medicinal value due to its anti-inflammatory effect. Its main role is to enhance the bioavailability of various therapeutic agents such as curcumin and lycopene as it inhibits their hepatic and intestinal glucuronidation.[5] In humans, concomitant administration of piperine (20 mg) produces much higher concentrations of curcumin administered 1-h postdrug and its bioavailability increases by 2000%. Piperine enhances the serum concentrations, extent of absorption and bioavailability of curcumin in both rats and humans with no undesirable effects.[6] The aim of the present study is to evaluate the effects of systemically administered curcumin, piperine and lycopene as an adjunct to scaling and root planing (SRP) in patients with moderate gingivitis.

Study design

Subjects

This study was conducted on 60 participants with chronic generalized gingivitis aged between 18 and 55 years attending the Department of Periodontics, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, Punjab. The participants included in the study were in good general health and met the following criteria: Systemically healthy participants Minimum of 20 natural teeth Age group between 18 to 55 years Moderately/severely inflamed gingiva with swollen gums which bleed on probing.

Exclusion criteria

Any systemic disease such as diabetes, cardiovascular diseases and renal diseases Pregnant or lactating women Individuals with history of consumption of antibiotic therapy within previous 6 months History of consumption of anti-inflammatory drugs within the previous 3 months.

Design

The selected participants were divided into two groups: Group I: 30 participants having chronic generalized gingivitis treated with SRP alone Group II: 30 participants having chronic generalized gingivitis treated with SRP along with 350 mg (curcumin 300 mg, piperine 5 mg and lycopene 10 mg) given for 21 days twice a day. The antioxidant therapy was given systemically in the dosage of 350 mg over 3 weeks. Each capsule was composed of curcumin, piperine and lycopene.

Clinical parameters

The clinical parameters evaluated were: Plaque index (PI) (Silness and Loe, 1964) Gingival index (GI) (Loe and Silness, 1963) and Probing pocket depth (PPD). PPD was measured with Williams probe and acrylic stent as a guide for reproducibility from the gingival margin to base of the pocket. The proposed study was reviewed by the ethic committee of the institution and clearance was obtained. Informed consent was obtained from each participant before conducting the trial. The procedures followed were in accordance with the Helsinki Declaration of 2000.

Statistical analysis

Statistical analysis for the post treatment changes in various clinical parameters was performed at baseline and by paired t-test and P < 0.05 was considered as statistical significant difference.

Results

Sixty participants with chronic generalized gingivitis were included in this study. Intergroup comparison of clinical parameters at baseline and 21 days was recorded using paired t-test. The mean score of PI for patients of Group I (gingivitis patients treated with SRP alone) was 1.52 ± 0.20 at baseline and 0.93 ± 0.21 at 3rd week and for GI, it was 1.71 ± 0.25 at baseline and 0.95 ± 0.20 at 3 weeks. Probing depth (PPD) mean score at baseline was 1.84 ± 0.22 and it reduced to 1.50 ± 0.15 at 3rd week [Tables 1 and 2].
Table 1

Comparison of plaque index, gingival index, probing depth of test and control group

Table 2

Comparison of percentage between test and control group reduction in plaque index, gingival index, and probing depth at baseline and 3 weeks

Comparison of plaque index, gingival index, probing depth of test and control group Comparison of percentage between test and control group reduction in plaque index, gingival index, and probing depth at baseline and 3 weeks The mean score of PI for patients of Group II (gingivitis patients treated with SRP and antioxidant therapy) was 1.38 ± 0.27 at baseline and 0.74 ± 0.17 at 3rd week. For GI, the values for mean score were 1.73 ± 0.28 at baseline and 0.77 ± 23 at 3 weeks. In this group, PPD score reduced from 1.74 ± 0.22 to 1.25 ± 0.15 at 3rd week [Tables 1 and 2]. On comparison between Group I and II using paired t-test, statistically significant difference was observed in all the parameters with highly significant reduction in GI (P < 0.003) at 3rd week.

Discussion

The effect of metabolic ROS cannot be overlooked in the multitude of various mechanisms which lead to the destruction of gingival and periodontal tissues.[7] The healthy gingival connective tissue and epithelium demonstrate polymorphonuclear leukocytes (PMNLs) as predominant cells (96%) and the presence of periodontopathic bacteria functionally activates PMNLs leading to increased production of ROS. Chronic inflammation subjects the nearby cells to increased levels of ROS due to extracellular release from phagocytic cells.[8] In order to study the damaging effect of ROS and the antioxidant protection against bacterial action, the periodontal and gingival tissues provide the principle environment.[7] Hence, the periodontal diseases can be treated by various researchers by including antioxidant therapy as a part of periodontal protocol. In this context, the present study has evaluated the effects of systemically administered extracts of curcumin, piperine and lycopene as an adjunct to SRP in patients with moderate gingivitis. In the current study, on intergroup comparison, PI, GI and bleeding scores between the test and the control groups showed statistically significant results at 21st day interval. Furthermore, mean significant percentage reduction of scores was found in both the groups with greater reduction in test group [Graph 1]
Graph 1

Comparison of percentage reduction in plaque index, gingival index, and probing depth in Group 1 and 2. P < 0.05 (significant)

Comparison of percentage reduction in plaque index, gingival index, and probing depth in Group 1 and 2. P < 0.05 (significant) Curcumin exerts a very potent anti-inflammatory,[910] antibacterial[11] and antioxidant[12] effect which leads to reduction in bleeding on probing and redness via: Reduction of the inflammatory mediators generated through arachidonic acid metabolite pathway. It causes nuclear factor kappa B (NF-kB) activation[131415] inhibition and pro-inflammatory enzyme cyclooxygenase-2[1415] downregulation The vascularization by fibrosis of the connective tissue[16] occurs by promotion of migration of various cells including fibroblasts in wound bed. This enhances wound healing by causing an increase in the number of fibroblasts[17] leading to greater reduction in PPD in test group. Behal et al.[18] concluded that the experimental local drug-delivery system containing 2% whole turmeric gel can be used as an adjunct to SRP as it helps in reduction of pocket depth and gain of clinical attachment. Gottumukkala et al.[19] studied the effectiveness of subgingival irrigation of indigenous 1% curcumin solution and concluded mild-to-moderate beneficiary effect of curcumin irrigation when used as an adjunct to SRP. Muglikar et al.[20] studied the efficacy of curcumin mouthwash as an adjunct to SRP in the treatment of chronic gingivitis and to compare chlorhexidine in terms of its anti-inflammatory and antimicrobial properties. They concluded that curcumin is comparable to chlorhexidine as an anti-inflammatory mouthwash and it is an effective adjunct to mechanical periodontal therapy. Curcumin has shown to effectively inhibit cytokine gene expression at mRNA and protein levels and NF-kB is inhibited only with the lower dose of curcumin with significant reduction of the inflammatory infiltrate and increased collagen content and fibroblastic cell numbers which could explain the reduction in PPD along with bleeding on probing in the participants.[21] Elburki et al.[21] have shown that a novel chemically modified curcumin reduces the severity of experimental periodontal disease in rats. Lycopene is one of the most effective antioxidants found in tomatoes and has a singlet oxygen quenching ability which provides prevention against various chronic disorders.[3] It has been classified to the class of compounds known as carotenoids which are the yellow, orange and red pigments produced by plants.[22] Lycopene has the exceptional feature of binding to chemical species that react with oxygen, thus being the most competent biological antioxidizing agent.[23] Di Mascio et al.[24] showed that lycopene is the most efficient biological carotenoid singlet oxygen quencher. Chandra et al.[7] and Arora et al.[25] concluded in their studies that systemic lycopene and oral prophylaxis showed statistically significant reduction in GI, compared to placebo oral prophylaxis group. In both the studies, patients were followed up for 2 weeks in gingivitis patients and 2 months in chronic periodontitis patients respectively. Piperine acts by inhibiting or quenching free radicals and ROS. It also enhances the bioavailability of various therapeutic agents such as curcumin and lycopene as it inhibits their hepatic and intestinal glucuronidation.[5] Shoba et al.[6] evaluated the bioavailability of curcumin in rats and healthy human volunteers. When curcumin was given alone, in the dose 2 g/kg to rats, moderate serum concentrations were achieved over a period of 4 h. Concomitant administration of piperine 20 mg/kg increased the serum concentration of curcumin for a short period of 1–2 h postdrug without any undersirable effect. Hence, the synergistic effect of curcumin and piperine enhances the reduction in clinical parameters.

Conclusion

The antioxidant therapy has emerged as an important part of conventional periodontal therapy. Diet low in antioxidants predispose an individual at increased risk of developing gum disease as well as destruction of periodontal tissue. Hence, the antioxidant status needs to be evaluated along with the periodontal protocols. Nutritional supplementation and balanced diet should be an integral part of periodontal research as well as treatment protocol to enhance the outcome of conventional periodontal therapy.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  22 in total

Review 1.  Role of antioxidant lycopene in cancer and heart disease.

Authors:  A V Rao; S Agarwal
Journal:  J Am Coll Nutr       Date:  2000-10       Impact factor: 3.169

Review 2.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells.

Authors:  H Chen; Z S Zhang; Y L Zhang; D Y Zhou
Journal:  Anticancer Res       Date:  1999 Sep-Oct       Impact factor: 2.480

Review 4.  Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).

Authors:  Nita Chainani-Wu
Journal:  J Altern Complement Med       Date:  2003-02       Impact factor: 2.579

Review 5.  Reactive oxygen species and antioxidants in inflammatory diseases.

Authors:  I L Chapple
Journal:  J Clin Periodontol       Date:  1997-05       Impact factor: 8.728

6.  Lycopene as the most efficient biological carotenoid singlet oxygen quencher.

Authors:  P Di Mascio; S Kaiser; H Sies
Journal:  Arch Biochem Biophys       Date:  1989-11-01       Impact factor: 4.013

7.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.

Authors:  G Shoba; D Joy; T Joseph; M Majeed; R Rajendran; P S Srinivas
Journal:  Planta Med       Date:  1998-05       Impact factor: 3.352

8.  Effectiveness of sub gingival irrigation of an indigenous 1% curcumin solution on clinical and microbiological parameters in chronic periodontitis patients: A pilot randomized clinical trial.

Authors:  Sruthima N V S Gottumukkala; Suneetha Koneru; Satheesh Mannem; Narendra Mandalapu
Journal:  Contemp Clin Dent       Date:  2013-04

9.  Antioxidant therapy as monotherapy or as an adjunct to treatment of periodontal diseases.

Authors:  Aditi Mathur; Lalit Mathur; Balaji Manohar; Hemant Mathur; Rajesh Shankarapillai; Neema Shetty; Aman Bhatia
Journal:  J Indian Soc Periodontol       Date:  2013-01

10.  A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations.

Authors:  Muna S Elburki; Carlos Rossa; Morgana R Guimaraes; Mark Goodenough; Hsi-Ming Lee; Fabiana A Curylofo; Yu Zhang; Francis Johnson; Lorne M Golub
Journal:  Mediators Inflamm       Date:  2014-06-29       Impact factor: 4.711

View more
  4 in total

1.  Local application of curcumin-loaded nanoparticles as an adjunct to scaling and root planing in periodontitis: Randomized, placebo-controlled, double-blind split-mouth clinical trial.

Authors:  Cindy Grace Pérez-Pacheco; Natalie Ap Rodrigues Fernandes; Fernando Lucas Primo; Antonio Claudio Tedesco; Emily Bellile; Belen Retamal-Valdes; Magda Feres; Morgana Rodrigues Guimarães-Stabili; Carlos Rossa
Journal:  Clin Oral Investig       Date:  2020-10-30       Impact factor: 3.573

2.  The Effects of Curcumin in the Treatment of Gingivitis: A Systematic Review of Clinical Trials.

Authors:  Farinaz Shirban; Fateme Gharibpour; Ailin Ehteshami; Mohammad Bagherniya; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  From Simple Mouth Cavities to Complex Oral Mucosal Disorders-Curcuminoids as a Promising Therapeutic Approach.

Authors:  Sosmitha Girisa; Aviral Kumar; Varsha Rana; Dey Parama; Uzini Devi Daimary; Saman Warnakulasuriya; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-17

4.  Curcumin and its analog alleviate diabetes-induced damages by regulating inflammation and oxidative stress in brain of diabetic rats.

Authors:  Chengfeng Miao; Hanbin Chen; Yulian Li; Ying Guo; Feifei Xu; Qi Chen; Yanyan Zhang; Mengjun Hu; Guorong Chen
Journal:  Diabetol Metab Syndr       Date:  2021-02-18       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.